Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yizeda Pharmaceutical Technology is a research-driven contract research organization (CRO) based in the Zhangjiang Hi-Tech Park of Shanghai, China. Founded in 2012, the company specializes in small molecule drug discovery services, including medicinal chemistry, custom organic synthesis, and lead optimization. Yizeda supports a global clientele of pharmaceutical and biotechnology companies through flexible service models such as Full-Time Equivalent (FTE) and Fee-for-Service (FFS). The firm's core expertise lies in the design and synthesis of complex organic molecules, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs) for research purposes. By leveraging a team of experienced chemists and modern laboratory facilities, Yizeda aims to accelerate the R&D timelines of its partners in therapeutic areas such as oncology and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yizeda Pharmaceutical Technology.